The advancement makes it possible for gene sequencing businesses and research institutions from all over the world to acquire precise and effective analysis services while adhering to each nation’s regulatory standards, leading to cheaper costs and more efficacy for healthcare and research.

Using Amazon Web Services, Chi-Biotech (“Chi-Biotech” or “the Company”) has successfully deployed its FANSe-based Next-Generation Sequencing analytics solution after a two-year effort (AWS).

The free and accurate solution, which is now accessible to customers everywhere, has the potential to drastically lower costs and boost efficacy for scientific research and precision medicine globally.

Numerous billions of DNA fragments are simultaneously sequenced during next-generation sequencing. Almost all biological applications begin with matching these sequences to the reference genome. Consequently, accuracy and speed are both required. Current algorithmic pipelines are suboptimal since the equipment and experimental methods have long been standardised. Repeated testing of the same material can provide wildly varied findings, and processing frequently takes days. The FANSe series algorithms were created by Chi-Biotech to address these issues. Without compromising speed, accuracy is given priority. It achieved and still retains the world record for the quickest five-minute analysis of the full human genome on a single computer in 2020.

Source: Prnewswire